Back to search

Article

The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice

2022-09-10

Abstract excerpt

<h4>Background & Aims</h4> Chronic hepatitis B is a major global public health problem, and coinfection with hepatitis delta virus (HDV) worsens disease outcome. Here, we describe a hepatitis B virus (HBV) surface antigen (HBsAg)-targeting monoclonal antibody (mAb) with the potential to promote functional cure of chronic hepatitis B and D to address this unmet medical need. <h4>Methods</h4> HBsAg-specific mAbs w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5dca264c-0fd9-5e55-82ae-85df26ec488d
DOI
10.1101/2022.09.09.507326
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized miceDOI 10.1101/2022.09.09.507326
Select a neighboring publication to make it the new centre.